The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PCRX FINANCIAL STATEMENTS

Pacira BioSciences, Inc. — balance sheet, income statement and cash flow trends

PCRXPacira BioSciences, Inc.

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0250 M500 M750 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue746.2 M $Gross Profit591 M $ · 79%Operating Income18.4 M $ · 2%Pre-tax Income17.6 M $ · 2%Net Income to Owners14.6 M $ · 2%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue746.2 M $+5.7%
Gross Profit591 M $+7.1%
Operating Income18.4 M $—
EBITDA114.8 M $—
Net Income to Owners14.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.2 B
  • Equity672 M $54%
  • Current Liabilities122 M $10%
  • Long-term Liabilities450 M $36%

Key Figures

YoY change
Total Assets1.2 B $-19.1%
Total Liabilities572 M $-26.6%
Total Equity672 M $-11.3%
Cash & ST Investments251 M $-43.7%
Total Debt412.1 M $-34.7%
Net Debt206.2 M $-37.7%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M187.7 M $Operating94.1 M $Investing-376.2 M $Financing-94.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow187.7 M $+39.5%
Capital Expenditures8.1 M $-53.3%
Free Cash Flow179.5 M $+53.3%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PCRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.